These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 648997)
41. Management and therapy of polycythaemia vera. Israëls MC Br J Haematol; 1969 Sep; 17(3):305. PubMed ID: 5257763 [No Abstract] [Full Text] [Related]
42. Treatment of polycythemia vera. MacDougall BK; Weinerman BH; Kemel S Can Med Assoc J; 1979 Sep; 121(5):581-2, 584. PubMed ID: 497948 [No Abstract] [Full Text] [Related]
43. [The treatment of myeloproliferative syndromes]. Maurice P Schweiz Med Wochenschr; 1975 Oct; 105(40):1269-74. PubMed ID: 1061995 [TBL] [Abstract][Full Text] [Related]
44. [A clinical and biological study of 33 cases of polycythemia vera]. Corredoira JC; González M; Pérez R; Casariego E; López MJ; García JF; Arias J Rev Clin Esp; 1990 May; 186(8):378-82. PubMed ID: 2236766 [TBL] [Abstract][Full Text] [Related]
45. Treatment of polycythaemia vera with reinfusion of autologous blood plasma obtained by phlebotomy. Stefanović S; Radotić M; Dukić M; Ristić M; Banićević B; Jancić MS; Maslovarić S Haematologia (Budap); 1974; 8(1-4):473-6. PubMed ID: 4461432 [No Abstract] [Full Text] [Related]
46. Major surgery in patients with polycythaemia vera. Rudowski W; Klawe Z; Woźniewska M; Ziemski JM Haematologia (Budap); 1974; 8(1-4):477-83. PubMed ID: 4461433 [No Abstract] [Full Text] [Related]
47. [Polycythemia vera and pregnancy: difficulties for diagnosis and treatment]. Deruelle P; Bouhassoun J; Trillot N; Jude B; Ducloy AS; Subtil D Gynecol Obstet Fertil; 2005 May; 33(5):331-7. PubMed ID: 15878688 [TBL] [Abstract][Full Text] [Related]
49. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Nand S; Stock W; Godwin J; Fisher SG Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610 [TBL] [Abstract][Full Text] [Related]
50. Polycythemia vera: a retrospective and reprise. Berlin NI; Wasserman LR J Lab Clin Med; 1997 Oct; 130(4):365-73. PubMed ID: 9358074 [TBL] [Abstract][Full Text] [Related]
51. The use of 32 phosphorus (32P) in the treatment of polycythemia vera. Parmentier C; Gardet P Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140 [TBL] [Abstract][Full Text] [Related]
52. [Treatment of erythremia]. Demidova AV Ter Arkh; 1974; 46(9):114-20. PubMed ID: 4439294 [No Abstract] [Full Text] [Related]
53. Management of patients with polycythaemia vera: results of a survey among Swedish haematologists. Andreasson B; Löfvenberg E; Westin J Eur J Haematol; 2005 Jun; 74(6):489-95. PubMed ID: 15876252 [TBL] [Abstract][Full Text] [Related]
54. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature. Swolin B; Rödjer S; Westin J Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338 [TBL] [Abstract][Full Text] [Related]
55. The treatment of polycythemia vera. Wasserman LR Semin Hematol; 1976 Jan; 13(1):57-78. PubMed ID: 1251223 [No Abstract] [Full Text] [Related]
56. Aquagenic pruritus in polycythemia vera: characteristics and influence on quality of life in 441 patients. Siegel FP; Tauscher J; Petrides PE Am J Hematol; 2013 Aug; 88(8):665-9. PubMed ID: 23657863 [TBL] [Abstract][Full Text] [Related]
57. Polycythemia vera. A clinical study of 141 patients. Anger B; Haug U; Seidler R; Heimpel H Blut; 1989 Dec; 59(6):493-500. PubMed ID: 2597774 [TBL] [Abstract][Full Text] [Related]
58. Survival of patients with polycythemia vera on busulfan or 32P. Mathé G N Engl J Med; 1978 Feb; 298(5):279. PubMed ID: 619270 [No Abstract] [Full Text] [Related]
59. Polycythemia vera and agnogenic myeloid metaplasia. Reed RE Med Clin North Am; 1980 Jul; 64(4):667-81. PubMed ID: 6995729 [TBL] [Abstract][Full Text] [Related]